论文部分内容阅读
作者对接受热疗的90名肿瘤病人进行了免疫反应动态研究。计乳腺癌74例,直肠癌、胃癌、肺癌、黑色素瘤共16例。诊断是依据临床特征和组织学、放射学检查的资料.病人年龄为18～65岁。以免疫学指标正常的80名健康人为对照组。分别在治疗前,治疗期(高峰)和治疗后1、3、7、14、20、30、40天进行免疫指标测定.大部分病人观察数月、少部分观察数年.在热疗的同时加用高血糖治疗,采用静脉注入40%葡萄糖而使肿瘤过酸化.热疗采用Pettigrew
The authors conducted a dynamic study of the immune response of 90 patients undergoing hyperthermia. There were 74 cases of breast cancer, 16 cases of rectal cancer, gastric cancer, lung cancer, and melanoma. The diagnosis is based on clinical features, histology, and radiological examinations. The patient’s age is 18 to 65 years old. The control group consisted of 80 healthy individuals with normal immunological parameters. Before treatment, treatment period (peak) and 1, 3, 7, 14, 20, 30, and 40 days after treatment, immunological markers were measured. Most patients were observed for several months and few were observed for several years. Hyperglycemia treatment is used to infuse 40% glucose to over-acidify the tumor. Hyperthermia is based on Pettigrew.